首页> 外文期刊>Upsala journal of medical sciences >A Two-site Delfia Immunoassay for Measurements of the N-terminal Peptide of pro-Atrial Natriuretic Peptide (nANP)
【24h】

A Two-site Delfia Immunoassay for Measurements of the N-terminal Peptide of pro-Atrial Natriuretic Peptide (nANP)

机译:两点Delfia免疫测定法,用于测定心房利钠肽(nANP)的N端肽

获取原文
           

摘要

A rapid, sensitive and reliable two-site immunoassay for measurements of the N-terminal peptide of pro-atrial natriuretic peptide (nANP) is presented. The method uses one monoclonal antibody, directed against the N-terminal part of nANP, as catcher antibody and another monoclonal antibody, directed against the C-terminal part of nANP, as detector antibody. The catcher antibody is biotinylated and is bound to streptavidin pre-coated microtiter strips. The detector antibody is labelled with Europium, which is measured in a Wallac DELFIA time-resolved fluorometer. Blood collected in plain Vacutainerr` tubes gave same measured amounts of nANP as blood collected in heparinised tubes. Blood collected in tubes containing EDTA gave same measured amounts of nANP as the plain tubes, provided that a 2-step assay protocol was used. Based upon 100 healthy blood donors, a reference interval was calculated to <450 pmol/L. Within the reference group there was a significant increase of serum nANP with age. Based on 42 patients with different degree of impaired renal function, a significant correlation of nANP and serum creatinine was found. Assay performance, given as total assay variation was 12%, 10% and 9% respectively at serum levels of 140, 970 and 3500 pmol/L. It is concluded that this method is fast, sensitive and reliable for clinical measurements of nANP.
机译:提出了一种快速,灵敏和可靠的两点免疫测定法,用于测定心房利钠肽(nANP)的N末端肽。该方法使用一种针对nANP N端部分的单克隆抗体作为捕获抗体,另一种针对nANP C端部分的单克隆抗体作为检测抗体。捕获抗体被生物素化,并与抗生蛋白链菌素预包被的微量滴定条结合。检测器抗体标有Euro,可在Wallac DELFIA时间分辨荧光计中测量。在普通的Vacutainer r` 管中收集的血液与肝素化管中收集的血液具有相同的nANP测量值。假设使用两步测定方案,在装有EDTA的试管中收集的血液可测得与普通试管相同的nANP量。基于100名健康献血者,参考间隔被计算为<450 pmol / L。在参考组中,血清nANP随年龄增长而显着增加。根据42位不同程度肾功能受损的患者,发现nANP与血清肌酐存在显着相关性。血清总水平为140、970和3500 pmol / L时,总检测差异分别为12%,10%和9%。结论是,该方法对于nANP的临床测量是快速,灵敏和可靠的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号